These effects are usually mild to moderate and most noticeable during the first weeks of treatment or after a dose increase
no completed Phase 1-3 human trials
WARNING: Do not put in eyes, mouth, or ears
While GLP-1 medications can be administered at any time of day (consistent with prescribing information), some patients report personal preference for evening administration
| 2024 Edition Researchers seeking tesamorelin for their work are well-advised to evaluate potential vendors on aspects like quality assurance, customer service, payments accepted, and shipping times
Unapproved peptide products, particularly those that are injected, carry significant safety risks, including contamination, infection or local tissue damage